In a new case study, researchers in China have published details about ... from a blood sample to find the virus responsible ...

On November 4, 2024, the CDC confirmed 44 cases of A (H5N1) in the United States. The first human case was reported in Texas ...

Shenzhen Institutes of Advanced Technology study reveals some species, such as monarch butterflies, less likely to contract ...

China is the fourth major market where Kisunla has been approved after the US, Japan, and GB. It gets the green light there ...

These treat conditions like hypertrophic cardiomyopathy, and intractable epilepsy. China’s National Healthcare Security ...

The new version, jointly issued by the National Health Commission and three other government departments, lists 135 diseases in 12 categories, compared to the current version, which includes 132 ...

As Cytokinetics’ aficamten awaits approval decisions from regulators in the U.S. and China, Sanofi has picked up China rights ...

In addition, China has also made efforts to accelerate the approval of new drugs already in the overseas ... for chronic obstructive pulmonary disease. The drug's approval was granted even faster ...

Announcing a new article publication for Zoonoses journal. Leptospirosis is a re-emerging zoonotic disease that significantly impacts animals and human health worldwide.

Higher intakes of artificially sweetened and sugar-sweetened beverages) are associated with an elevated risk for chronic kidney disease.

Announcing a new article publication for Zoonoses journal. Leptospirosis is a re-emerging zoonotic disease that significantly impacts animals and human health worldwide. China has diverse climate ...